Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crawford & Company A | CRD-A | Nov 4, 2024 | 11.56 | +4.62 |
Crawford & Company B | CRD-B | Nov 4, 2024 | 11.34 | +1.80 |
Creative Media & Community Trust | CMCT | Nov 4, 2024 | 0.38 | +6.23 |
Creative Medical Technology | CELZ | Nov 4, 2024 | 3.51 | -12.69 |
Creative Realities | CREX | Nov 4, 2024 | 3.97 | -5.02 |
Credicorp | BAP | Nov 4, 2024 | 181.52 | -0.13 |
Credit Acceptance | CACC | Nov 4, 2024 | 423.62 | +1.51 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Nov 4, 2024 | 27.04 | -0.81 |
Credit Suisse Ag | SLVO | Nov 4, 2024 | 82.30 | +0.51 |
Credit Suisse Ag | GLDI | Nov 4, 2024 | 158.64 | +0.10 |
Credit Suisse Asset Management Income Fund | CIK | Nov 4, 2024 | 2.94 | -0.68 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Nov 4, 2024 | 66.09 | +2.61 |
Credit Suisse High Yield Bond Fund | DHY | Nov 4, 2024 | 2.14 | -0.47 |
Credo Technology | CRDO | Nov 4, 2024 | 40.07 | -0.89 |
Crescent Capital BDC | CCAP | Nov 4, 2024 | 17.55 | -2.61 |
Crescent Energy | CRGY | Nov 4, 2024 | 12.53 | +2.20 |
Cresud A ADR | CRESY | Nov 4, 2024 | 9.14 | +1.44 |
Crexendo | CXDO | Nov 4, 2024 | 5.73 | +1.06 |
CRH | CRH | Nov 4, 2024 | 94.45 | -1.41 |
Cricut A | CRCT | Nov 4, 2024 | 6.37 | -1.55 |
Crinetics Pharmaceuticals | CRNX | Nov 4, 2024 | 56.82 | +0.23 |
CRISPR Therapeutics | CRSP | Nov 4, 2024 | 50.59 | -0.33 |
Criteo ADR | CRTO | Nov 4, 2024 | 34.40 | +2.87 |
Critical Metals | CRML | Nov 4, 2024 | 6.25 | -0.79 |
Crocs | CROX | Nov 4, 2024 | 106.29 | +0.08 |
Cronos Group | CRON | Nov 4, 2024 | 2.20 | +1.85 |
Cross Country Healthcare | CCRN | Nov 4, 2024 | 11.22 | -0.97 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 4, 2024 | 10.06 | +2.03 |
CrossAmerica Partners LP Unit | CAPL | Nov 4, 2024 | 20.54 | -3.39 |
CrossFirst Bankshares | CFB | Nov 4, 2024 | 15.47 | -1.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.